Background Image

Türkiye Aşı Enstitüsü

Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, inhealthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, inhealthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials

Haziran 9, 2026
DEVAMINI OKU
Assessment of participant-reported adverse events following the two doses of inactivated SARS-CoV-2 vaccine through a telephone survey in Türkiye
Assessment of participant-reported adverse events following the two doses of inactivated SARS-CoV-2 vaccine through a telephone survey in Türkiye

Haziran 9, 2026
DEVAMINI OKU
Development of an Inactivated Vaccine against SARS CoV-2
Development of an Inactivated Vaccine against SARS CoV-2

Haziran 9, 2026
DEVAMINI OKU